Comments on: The United States Isn’t Immune to Counterfeit Drugs

By: A Puzzling Prescription: Pharmaceutical Industry Trends Pose New Regulatory and Recall Challenges

Wed, 17 Feb 2016 15:20:20 +0000

[…] in 2015 — more than double the number approved just ten years ago. The counterfeit drug industry, worth roughly $200 billion annually, also continues to grow. According to the FDA, this trend is due to […]

By: A Puzzling Prescription: Pharmaceutical Industry Trends Pose New Regulatory and Recall Challenges « Contacto Latino News

Wed, 17 Feb 2016 15:08:36 +0000

[…] — more than double the number approved just ten years ago. The counterfeit drug industry, worth roughly $200 billion annually, also continues to grow. According to the FDA, this trend is due to […]

By: JenkinsAuthor

JenkinsAuthor — Sun, 10 May 2015 00:17:36 +0000

Explainer:The U.S. Isn’t Immune to Counterfeit Drugs by @jessicamarilyn8 – http://t.co/PJkN3cqQNa #FakeDrugs #Health via @LawStreetMedia

By: Jessicamarilyn8

Jessicamarilyn8 — Fri, 08 May 2015 13:56:01 +0000

RT @LawStreetMedia: The United States Isn’t Immune to #CounterfeitDrugs by @jessicamarilyn8 http://t.co/ycbQnTjJK7 #BlackMarket #Drugs #Med…